Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD-Authors' reply

Aliment Pharmacol Ther. 2024 Jun;59(12):1646-1647. doi: 10.1111/apt.18031. Epub 2024 May 10.

Arta Aliu^{1

2}, Daan H C A Bosch^{1

2}, Daniel Keszthelyi^{1

2}, Ashkan Rezazadeh Ardabili^{1

2}, Jean-Frederic Colombel³, Rachel Sawyer⁴, Hans Törnblom⁵, Ailsa Hart⁶, Daisy M A E Jonkers^{1

2}, Marieke J Pierik^{1

2}, Zlatan Mujagic^{1

2}

¹ Department Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, The Netherlands.
² NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
³ Department of Medicine, The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
⁴ IBD Patient Advocacy, Founder of the Bottom Line IBD and IBD Women, London, UK.
⁵ Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
⁶ IBD Unit, St Mark's Hospital & Imperial College, London, UK.

No abstract available

Publication types